We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
-4.46%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$18.3B
AUM Growth
-$3.9B
(-18%)
Cap. Flow
-$2.31B
Cap. Flow
% of AUM
-12.59%
Top 10 Holdings %
Top 10 Hldgs %
30.49%
Holding
560
New
66
Increased
141
Reduced
222
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$317M |
| 2 |
Yum! Brands
YUM
|
+$222M |
| 3 |
CELG
Celgene Corp
CELG
|
+$213M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$211M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$194M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$264M |
| 2 |
Blackstone
BX
|
+$256M |
| 3 |
Cigna
CI
|
+$232M |
| 4 |
Hartford Financial Services
HIG
|
+$206M |
| 5 |
CVS Health
CVS
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.98% |
| 2 | Technology | 17.05% |
| 3 | Consumer Discretionary | 15.78% |
| 4 | Communication Services | 12.84% |
| 5 | Financials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRMN
401
Garmin
GRMN
$46.6B
| $785K | ﹤0.01% |
21,866
| – | – |
|
|
BCR
402
DELISTED
CR Bard Inc.
BCR
| $755K | ﹤0.01% |
+4,050
| New | +$767K |
|
|
GBT
403
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $753K | ﹤0.01% |
+17,850
| New | +$842K |
|
404
Las Vegas Sands
LVS
$31.3B
| $751K | ﹤0.01% |
19,784
| – | – |
|
405
Williams Companies
WMB
$87.8B
| $749K | ﹤0.01% |
20,316
-50,550
| -71% | -$2.52M |
|
|
ALPN
406
DELISTED
Alpine Immune Sciences Inc
ALPN
| $745K | ﹤0.01% |
14,363
| – | – |
|
|
SCTY
407
DELISTED
SolarCity Corporation
SCTY
| $738K | ﹤0.01% |
17,275
-3,125
| -15% | -$157K |
|
408
Merck
MRK
$327B
| $704K | ﹤0.01% |
14,934
+3,715
| +33% | +$197K |
|
409
PayPal
PYPL
$49.4B
| $682K | ﹤0.01% |
+21,968
| New | +$787K |
|
410
SAP
SAP
$199B
| $669K | ﹤0.01% |
10,330
| – | – |
|
|
CHMA
411
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $659K | ﹤0.01% |
+33,150
| New | +$823K |
|
|
CVA
412
DELISTED
Covanta Holding Corporation
CVA
| $658K | ﹤0.01% |
37,680
| – | – |
|
|
GWPH
413
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $658K | ﹤0.01% |
+7,200
| New | +$801K |
|
414
Itaú Unibanco
ITUB
$92.3B
| $650K | ﹤0.01% |
222,689
+90,840
| +69% | +$323K |
|
415
Duke Energy
DUK
$101B
| $648K | ﹤0.01% |
9,010
| – | – |
|
|
CALA
416
DELISTED
Calithera Biosciences, Inc
CALA
| $646K | ﹤0.01% |
5,950
+3,337
| +128% | +$432K |
|
|
CHMT
417
DELISTED
Chemtura Corporation
CHMT
| $637K | ﹤0.01% |
22,250
+4,935
| +29% | +$135K |
|
418
Credicorp
BAP
$30.9B
| $623K | ﹤0.01% |
5,857
+1,435
| +32% | +$173K |
|
419
Lincoln National
LNC
$8.01B
| $615K | ﹤0.01% |
12,950
| – | – |
|
|
CFMS
420
DELISTED
Conformis, Inc. Common Stock
CFMS
| $602K | ﹤0.01% |
+1,334
| New | +$672K |
|
|
DBVT
421
DBV Technologies
DBVT
$813M
| $593K | ﹤0.01% |
+1,665
| New | +$655K |
|
422
Berkshire Hathaway Class B
BRK.B
$1.07T
| $587K | ﹤0.01% |
4,500
-70,699
| -94% | -$9.69M |
|
|
POT
423
DELISTED
Potash Corp Of Saskatchewan
POT
| $561K | ﹤0.01% |
27,319
-131
| -0.5% | -$3.44K |
|
424
eBay
EBAY
$49B
| $554K | ﹤0.01% |
22,688
-31,219
| -58% | -$840K |
|
425
Cemex
CX
$17.4B
| $548K | ﹤0.01% |
84,845
-210,523
| -71% | -$1.56M |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q3 2015 Portfolio in Review
As of Q3 2015, Fred Alger Management held 560 positions worth $18.3B, down 18% from $22.2B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Fred Alger Management withdrew a net $2.31B in Q3 2015, closing 94 positions and reducing 222 holdings. Its most notable exit was Oracle, an estimated $104M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in Amgen worth $114M.
- Fred Alger Management's largest Q3 2015 buy was Amgen: 823,462 shares worth $114M.
- Fred Alger Management added most to Microsoft in Q3 2015, an estimated $317M increase.
- Fred Alger Management's biggest Q3 2015 reduction was Meta Platforms (Facebook), cutting an estimated $264M.
- Fred Alger Management fully exited Oracle in Q3 2015, selling an estimated $104M.
- Fred Alger Management's ten largest holdings make up 30% of its $18.3B portfolio in Q3 2015.
- Fred Alger Management opened 66 new positions and closed 94 in Q3 2015.
- Fred Alger Management's portfolio value fell 18% quarter-over-quarter to $18.3B.
Based on Fred Alger Management's 13F filing for Q3 2015, filed 16 Nov 2015.